share_log

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial

Benzinga Real-time News ·  Jun 30, 2022 20:45

Here's a roundup of top developments in the biotech space over the last 24 hours:

Stocks In Focus

US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine

Pfizer Inc(NYSE:PFE) andBioNTech SE(NASDAQ:BNTX) have announced a new vaccine supply agreement with the U.S. government.

The U.S. government will receive 105 million doses (30 µg, 10 µg, and 3 µg) for $3.2 billion. It may include adult omicron-adapted COVID-19 vaccines, subject to FDA authorization.

The U.S. government can purchase up to 195 million additional doses, bringing the total number of potential doses to 300 million.

FDA Institutes Partial Hold...

Login or create a forever free account to read this news
Sign up/Log in
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment